Consolidated Balance Sheets Statement - USD ($) $ in Thousands	Jun. 30, 2016	Dec. 31, 2015
CURRENT ASSETS:
Cash and cash equivalents	$ 14,778	$ 22,494
Accounts receivable, net of allowance for doubtful accounts of $2,940 and $4,136 at 2016 and 2015, respectively	111,752	145,689
Inventories	39,818	40,906
Prepaid expenses	10,912	12,053
Income taxes receivable	10,893	7,209
Other current assets	6,832	10,196
TOTAL CURRENT ASSETS	194,985	238,547
PROPERTY, PLANT AND EQUIPMENT, net	135,060	143,211
INTANGIBLES, net	9,700	10,041
GOODWILL	178,159	178,159
DEFERRED TAX ASSETS, net	9,537	11,693
OTHER ASSETS	44,665	43,607
TOTAL ASSETS	572,106	625,258
CURRENT LIABILITIES:
Accounts payable	29,404	33,474
Accrued payroll and related costs	34,512	36,475
Taxes other than payroll and income	6,714	9,495
Unearned revenue	11,114	14,101
Income taxes payable	1,352	1,733
Other current liabilities	13,119	25,480
TOTAL CURRENT LIABILITIES	96,215	120,758
LONG-TERM DEBT, net	208,237	430,987
DEFERRED COMPENSATION	43,570	43,478
DEFERRED TAX LIABILITIES, net	7,982	4,881
OTHER LONG-TERM LIABILITIES	49,151	48,853
COMMITMENTS AND CONTINGENCIES (Note 6)
Preference shares, EUR 0.02 par value; 6,000,000 shares authorized, none issued or outstanding	0	0
Common shares, EUR 0.02 par value; 200,000,000 shares authorized, 46,046,252 issued and 44,095,883 outstanding at 2016 and 44,350,002 issued and 42,375,905 outstanding at 2015	1,180	1,142
Additional paid-in capital	203,377	0
Retained earnings	204,287	219,207
Accumulated other comprehensive income (loss)	(11,605)	(10,538)
Treasury shares (at cost), 1,950,369 at 2016 and 1,974,097 at 2015	(235,388)	(238,875)
Total Core Laboratories N.V. shareholders' equity (deficit)	161,851	(29,064)
Non-controlling interest	5,100	5,365
TOTAL EQUITY (DEFICIT)	166,951	(23,699)
TOTAL LIABILITIES AND EQUITY (DEFICIT)	$ 572,106	$ 625,258